Flagship Pioneering’s Sana Biotechnology SANA Stock Holding History

Flagship Pioneering’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$87.3M	Hold	25,001,856	–	–	5.67%	3
2026 Q1	$72M	Hold	25,001,856	–	–	6.2%	3
2025 Q4	$102M	Hold	25,001,856	–	–	31.4%	2
2025 Q3	$88.8M	Hold	25,001,856	–	–	30.33%	2
2025 Q2	$68.3M	Hold	25,001,856	–	–	25.42%	2
2025 Q1	$42M	Hold	25,001,856	–	–	17.82%	3
2024 Q4	$40.8M	Hold	25,001,856	–	–	12.19%	3
2024 Q3	$104M	Hold	25,001,856	–	–	17.57%	3
2024 Q2	$137M	Hold	25,001,856	–	–	16.19%	2
2024 Q1	$250M	Hold	25,001,856	–	–	16.4%	2
2023 Q4	$102M	Hold	25,001,856	–	–	7.7%	2
2023 Q3	$96.8M	Sell	25,001,856 -8,288,162	-25%	-$44.5M	7.02%	2
2023 Q2	$198M	Sell	33,290,018 -949,000	-3%	-$5.47M	8.85%	2
2023 Q1	$112M	Hold	34,239,018	–	–	4.35%	4
2022 Q4	$135M	Hold	34,239,018	–	–	4.32%	3
2022 Q3	$205M	Hold	34,239,018	–	–	8.65%	2
2022 Q2	$220M	Hold	34,239,018	–	–	8.29%	2
2022 Q1	$283M	Hold	34,239,018	–	–	6.64%	2
2021 Q4	$530M	Hold	34,239,018	–	–	8.19%	2
2021 Q3	$771M	Hold	34,239,018	–	–	8.07%	2
2021 Q2	$673M	Hold	34,239,018	–	–	8.6%	3
2021 Q1	$1.15B	Buy	+34,239,018	New	+$1.11B	18.35%	2

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Flagship Pioneering's SANA Position: Q2 2026 in Review

Flagship Pioneering held its Sana Biotechnology (SANA) position steady in Q2 2026 at 25,001,856 shares worth $87.3M. The position accounts for 5.67% of the portfolio, ranked #3.

Flagship Pioneering first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.15B in Q1 2021. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

Flagship Pioneering held 25,001,856 shares of Sana Biotechnology worth $87.3M as of Q2 2026.
Flagship Pioneering left its Sana Biotechnology share count unchanged in Q2 2026.
Sana Biotechnology made up 5.67% of Flagship Pioneering's portfolio in Q2 2026, its #3 holding.
Flagship Pioneering first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
Flagship Pioneering's Sana Biotechnology position peaked at $1.15B in Q1 2021.
211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Flagship Pioneering's 13F filing for Q2 2026, filed 14 Aug 2026.